Diagnostics and OMICs

Abstract Number: PB1055

“Does my patient have HIT? There should be an app for that.”

F. Allemand¹, M. Stoll²

Abstract Number: OC 17.3

A collaborative study to harmonize thrombin generation assays for measurement of procoagulant activity in immune globulins

M. Shea¹, L. Parunov², S. Williams³, J. Hogwood³, S. Surov¹, Y. Liang¹, E. Gray³, M. Ovanesov¹

Abstract Number: PB1086

A comparative in vitro study of the coagulation effects of branded versus generic preparations of rivaroxaban

K. Mangion¹, K. Vella², A. Gatt³, D. Borg Aquilina⁴, N. Riva⁵

Abstract Number: PB1113

A method for measuring chromogenic factor VIII activity unbiased by the presence of the bispecific antibody Emicizumab

A. Weber, M. Billwein, A. Engelmaier, C. Zlabinger, G. Schrenk

Abstract Number: VPB1116

A novel material for the improvement of HIT detection

L. Chen¹, H. Nguyen²

Abstract Number: PB1111

A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

C. Van Laer¹, K. Freson², R. Lavend'homme², V. Muczynski³, K. Peerlinck⁴, C. Thys², M. Jacquemin⁵

Abstract Number: PB1057

A novel, easy-to-use ADAMTS13 activity assay using a fiber-optic surface plasmon resonance biosensor for diagnosis of thrombotic thrombocytopenic purpura

Q. Bonnez¹, E. Tellier², G. Kaplanski³, C. Tersteeg⁴, S. De Meyer⁴, K. Vanhoorelbeke⁴

Abstract Number: PB1091

A potential suitable alternative to Triton-X-100 for use in sample preparation for platelet nucleotide analysis

A. McCormick, A. Culhane, E. Bromidge

Abstract Number: PB0155

A potential use of leukocyte-platelet rich fibrin secretome to improve wound healing and bone regeneration

L. Hermida-Nogueira¹, J. Blanco², J. Reseland³, Á. García¹

Abstract Number: PB1090

A re-visit of the Pre-Kallikrein (Fletcher trait) assay to optimise for laboratory use

A. McCormick

Abstract Number: PB1063

A sensitive and user-friendly method for quantifying VWF collagen binding (VWF:CB) using a fiber optic – surface plasmon resonance biosensor

B. Calcoen¹, M. Jacquemin², C. Tersteeg³, K. Vanhoorelbeke³, S. De Meyer³

Abstract Number: PB1107

A specific threshold for ELISA detection of Von Willebrand alloantibodies in patients diagnosed as type 3 von Willebrand disease.

E. Jeanpierre¹, M. Desvages², F. Lassalle², S. Susen³

Abstract Number: PB1083

Accuracy Of The Hyphen Zymutest IgG ELISA Assay For Anti-Platelet Factor 4 Antibody Detection After ChAdOx1 nCov-19 Vaccination In Diagnosing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

E. Leitinger¹, J. Clifford¹, M. Parker¹, A. Iacobelli¹, P. Sung¹, V. CHEN², T. Brighton³, F. Passam⁴, L. Clarke⁵, H. Tran⁶, S. Chunilal¹

Abstract Number: PO0026

Activated Clotting Time : Setting Target Values of CPB when Changing from Hemochron Resopnse to i-STAT

T. KIM¹, S. Namgoong², M. Choi², S. Jang³

Abstract Number: VPB0148

ADAMTS-13 activity and silent brain infarction in patients with non-ischemic dilated cardiomyopathy

R. GÓMEZ DE ANTONIO¹, P. Martínez-Legazpi², E. Rodríguez González³, A. Fernández ávila³, G. Pérez Rus⁴, J. Díez Martín⁴, J. Bermejo Thomas³, C. Pascual Izquierdo⁴

Abstract Number: PB0158

AlphaFold and molecular dynamics structure predictions of mutations in serpins: lessons from antithrombin

P. Garrido-Rodríguez¹, M. Carmena-Bargueño², M. de la Morena-Barrio¹, C. Bravo-Pérez³, B. de la Morena-Barrio⁴, R. Cifuentes-Riquelme¹, V. Vicente¹, M. Lozano¹, H. Pérez-Sánchez², J. Corral¹

Abstract Number: OC 69.5

An integrative approach to diagnose heparin-induced thrombocytopenia: development, validation, and implementation of a multivariable prediction model

H. Nilius¹, A. Cuker², S. Haug³, C. Nakas⁴, J. Studt⁵, D. Tsakiris⁶, A. Greinacher⁷, A. Mendez⁸, A. Schmidt⁹, W. Wuillemin¹⁰, B. Gerber¹¹, J. Kremer Hovinga¹², P. Vishnu¹³, L. Graf¹⁴, A. Kashev³, R. Sznitman³, T. Backchoul¹⁵, M. Nagler¹⁶

Abstract Number: PB0164

Anti-inflammatory effect of archaeolipid nanovesicles on human endothelial cells

N. Charo¹, H. Jerez², S. Tatti³, E. Romero⁴, M. Schattner⁵

Abstract Number: PB1073

Anti-Xa and APTT stability in whole blood – a comparison of UFH & LMWH

P. Gajendra¹, C. Wigley¹, E. Foxton²

Abstract Number: VPB1121

Application of Next-generation sequencing in the study of inherited platelet disorders

G. Ramil López, I. Tirado, L. Romero, N. Vilalta